A Divergent Class of Arylamine N-Acetyltransferases Catalyzes Convergent Amidative Condensation of Polyketides in Manumycins Biosynthesis

This study identifies a novel class of arylamine N-acetyltransferases that catalyze a convergent amidative condensation between polyketide chains, establishing a new paradigm for combinatorial biosynthesis of complex amide-linked polyketides and enabling the generation of diverse non-natural therapeutics.

The Gist

Imagine nature as a massive, high-tech construction company. For decades, this company has built incredible structures called polyketides (complex molecules that often become life-saving drugs like antibiotics or cancer fighters). Usually, they build these structures using a very specific, assembly-line method called a "polyketide synthase" (PKS). Think of this like a conveyor belt where workers add one brick after another in a strict order.

Sometimes, to make a building stronger or more unique, they need to weld two separate sections together. In the past, scientists thought this "welding" (creating an amide bond) could only happen if the two sections were still on the conveyor belt, held by a special clamp called an ACP (Acyl Carrier Protein).

The Big Discovery
This paper reports a surprising discovery: Nature found a completely new way to weld these sections together. It's like finding a master carpenter who can take a section of wall that is still on the conveyor belt and perfectly weld it to a loose, free-floating section of wall sitting on the floor.

Here is the breakdown of how they found it and why it matters, using simple analogies:

1. The Mystery of the Missing Glue

Scientists were studying a group of natural products called Manumycins. These are like "molecular glue" drugs that can stop cancer cells from growing. They knew these drugs were made of two distinct chains (an "upper" chain and a "lower" chain) stuck together by a strong bond.

• The Puzzle: They knew how the two chains were built separately, but they couldn't find the "glue gun" (the enzyme) that stuck them together.
• The Suspect: They suspected a protein called Dar12 (and its cousin ColC2) was the glue gun. But there was a problem: Dar12 belongs to a family of enzymes usually known for "detoxifying" chemicals (like a janitor cleaning up spills), not for building complex structures.

2. The "Janitor" Who Became an Architect

The team tested Dar12 and ColC2 in a lab. They expected the enzymes to fail because the "lower" chain wasn't attached to the conveyor belt (ACP) as they thought it should be.

• The Surprise: The enzymes didn't just work; they worked amazingly well. They grabbed the "upper" chain (still attached to the conveyor belt) and the "lower" chain (sitting loose) and welded them together instantly.
• The Analogy: Imagine a janitor who usually just mops up spills. Suddenly, you hand them a loose brick and a brick still on a conveyor belt, and they instantly build a perfect archway between them. It's a completely different job for a janitor!

3. The Secret Door (The Structure)

To understand how they did it, the scientists took a 3D X-ray picture (crystal structure) of the enzyme ColC2.

• The Old Way: Most enzymes in this family have a narrow, straight hallway where they fit small, simple chemicals.
• The New Way: ColC2 has a huge, curved, custom-built tunnel.
  • The Entrance: The tunnel is wide open, allowing long, complex chains to enter easily.
  • The Twist: The enzyme has a special "lid" and a unique shape that forces the two chains to meet at a perfect angle to be welded.
  • The Metaphor: If a standard enzyme is a narrow tunnel for a bicycle, ColC2 is a wide, curved ramp designed for a semi-truck. It was built specifically to handle these massive, complex polyketide chains.

4. The "Universal Adapter"

The most exciting part is how flexible these enzymes are.

• The Test: The scientists tried feeding the enzyme all sorts of weird, non-natural ingredients. They swapped the "bricks" for different shapes, sizes, and colors.
• The Result: The enzyme didn't care! It happily welded almost anything together.
• The Analogy: Most enzymes are like a USB-C port that only fits one specific device. ColC2 is like a universal adapter that can plug in a phone, a laptop, a camera, or a toaster, and make them all work together.

Why Does This Matter?

This discovery changes the rules of the game for drug discovery.

1. New Drugs: Scientists can now use this "universal adapter" enzyme to mix and match different building blocks to create thousands of brand-new, never-before-seen drug candidates.
2. Faster Design: Instead of trying to re-engineer the entire assembly line (the PKS) to make a new drug, they can just use this enzyme to snap the pieces together at the end. It's like using a 3D printer to snap parts together rather than rebuilding the factory.
3. Understanding Nature: It shows that nature is more creative than we thought. Enzymes we thought were just "janitors" can actually be master architects.

In a Nutshell:
The scientists found a "Janitor" enzyme that turned out to be a "Master Builder." It has a special, wide-open tunnel that allows it to glue together two complex molecular chains in a way no one thought was possible. This gives scientists a powerful new tool to build custom-made medicines to fight diseases like cancer.

Technical Summary

1. Problem Statement

Polyketides are a major class of natural products with significant therapeutic potential, but their structural complexity often limits combinatorial biosynthesis. While amide bonds are critical for drug stability and affinity, their incorporation into polyketide frameworks typically relies on linear assembly by Non-Ribosomal Peptide Synthetases (NRPS).

• The Gap: The direct, convergent coupling of two independent polyketide chains via an amide bond has been a long-standing speculation, particularly for manumycin-type metabolites (e.g., asukamycin, novodaryamide). These compounds feature an "upper" polyketide chain linked to a "lower" chain containing an m-C7N core via a central amide bond.
• The Unknown: Despite the elucidation of the biosynthetic gene clusters (BGCs) for these metabolites, the specific enzyme responsible for this pivotal amidative condensation step remained uncharacterized. Previous hypotheses suggested an Arylamine N-acetyltransferase (NAT) might be involved, but NATs are traditionally known for detoxification (acetylating arylamines using acetyl-CoA) or specific intramolecular cyclizations, not intermolecular polyketide-polyketide coupling.

2. Methodology

The researchers employed a multidisciplinary approach combining bioinformatics, biochemistry, structural biology, and synthetic biology:

• Pathway Reconstitution & Biochemical Assays:
  • Shifted focus from asukamycin (due to protein solubility issues) to the novodaryamide A BGC from Streptomyces sp. CNQ-0859.
  • Expressed key enzymes: Dar12 (putative NAT), Dar6_N (ACP for the "lower" chain), and the AsuC PKS system (for the "upper" chain).
  • Performed in vitro reactions mixing ACP-tethered "upper" chains with free "lower" chain precursors (or free amines) in the presence of Dar12.
  • Used HPLC-HRMS to detect condensation products and feeding assays in Streptomyces lividans to verify downstream amidation steps.
• Structural Biology:
  • Since Dar12 crystallization failed, the homologous enzyme ColC2 (from the colabomycin BGC) was used as a surrogate.
  • Determined crystal structures of apo-ColC2 and ColC2 in complex with trans-2-octanoyl-SNAC (mimicking the ACP-tethered "upper" chain).
  • Performed Molecular Dynamics (MD) simulations and AlphaFold2 modeling to predict the interaction interface between ColC2 and its cognate ACP (AsuC5).
• Mutagenesis & Mechanistic Probing:
  • Generated site-directed mutants of ColC2 (catalytic triad, substrate-binding pocket residues, and ACP-interaction residues) to validate functional roles.
  • Compared ColC2 structures with Type I (MmNAT) and Type II (ShGdmF) NATs to identify structural divergences.
• Substrate Scope Evaluation:
  • Tested ColC2 with diverse acyl donors (CoA, SNAC, ACP-tethered, various chain lengths, and oxidation states) and a library of arylamine acceptors to assess promiscuity.

3. Key Contributions

• Discovery of a New Enzymatic Function: Identified Dar12 and its homolog ColC2 as a distinct Type III Arylamine NAT subclass. Unlike canonical NATs, these enzymes catalyze intermolecular amidative chain transfer/condensation between an ACP-tethered polyketide donor and a free polyketide acceptor.
• Elucidation of a Novel Biosynthetic Mechanism: Demonstrated that manumycin-type metabolites are assembled via a convergent strategy where the "upper" chain (synthesized by a KASIII-mediated PKS) is transferred from an ACP to a free "lower" chain (an arylamine-polyketide) by the NAT.
• Structural Basis for Functional Divergence: Revealed that ColC2 possesses a unique substrate-binding architecture that diverges significantly from canonical NATs, enabling the accommodation of large polyketide chains.
• Biocatalytic Platform: Established ColC2 as a versatile biocatalyst capable of generating a library of non-natural polyketide amides and manumycin derivatives through combinatorial biosynthesis.

4. Key Results

• Biochemical Characterization:

  • Dar12/ColC2 successfully catalyzed the condensation of an ACP-bound "upper" chain with a free "lower" chain (3-(3-amino-4-hydroxyphenyl)-propanoic acid), forming the core amide bond.
  • The enzyme rejects ACP-bound "lower" chains, confirming the reaction occurs between a tethered donor and a free acceptor.
  • The terminal amidation (converting the carboxylic acid to an amide) is performed by a separate enzyme, Dar24 (an asparagine synthetase homolog), acting after the condensation step.

• Structural Insights (ColC2):

  • Catalytic Mechanism: Retains the canonical NAT catalytic triad (Cys72-His110-Asp125). Cys72 attacks the thioester of the "upper" chain to form an acyl-enzyme intermediate, which is then attacked by the amine of the "lower" chain.
  • Unique Substrate Pocket:
    • Acyl Donor Channel: The $\alpha$6 helix is shifted outward by ~12°, and residue N71 (smaller than the tyrosine in other NATs) creates a large, solvent-accessible cavity capable of binding long polyketide chains (up to C14).
    • Acyl Acceptor Channel: Unlike other NATs where the CoA/ACP entry channel is lateral, ColC2 has a newly evolved vertical channel perpendicular to the acyl pocket. This is formed by replacing bulky residues (F204/M209 in other NATs) with smaller ones (L202/L207), allowing the "lower" chain to enter.
    • ACP Recognition: MD simulations and mutagenesis confirmed specific salt bridges and hydrophobic interactions between ColC2 (helix $\alpha$8) and the ACP (helix II), positioning the Ppant arm correctly for catalysis.

• Substrate Promiscuity & Application:

  • Acyl Donors: ColC2 accepts ACP-tethered chains, CoA-thioesters, SNAC-thioesters, and chains with varying lengths (C4–C8) and oxidation states (ketones, hydroxyls).
  • Arylamine Acceptors: The enzyme accepts a broad range of arylamines (e.g., toluidines, aniline, substituted phenols), producing diverse amide products.
  • Convergent Synthesis: Successfully generated a library of non-natural proto-manumycin analogs by swapping starter units and acceptor amines, demonstrating the potential for "plug-and-play" combinatorial biosynthesis.

5. Significance

• Paradigm Shift in Polyketide Biosynthesis: This work challenges the dogma that amide bond formation in polyketides requires NRPS modules. It reveals a convergent, NAT-mediated mechanism that links independent PKS pathways.
• Expansion of NAT Functionality: It redefines the functional scope of Arylamine NATs from simple detoxification enzymes to sophisticated biosynthetic tools capable of complex chain transfer and condensation.
• Drug Discovery Tool: The discovery of ColC2 provides a powerful biocatalyst for the rapid generation of novel polyketide scaffolds. Its broad substrate tolerance allows for the creation of "unnatural" natural products with potentially improved pharmacological properties (e.g., enhanced anticancer activity) without the need for complex engineering of PKS module specificity.
• Structural Biology: The identification of the unique substrate-entry tunnels in Type III NATs offers a blueprint for engineering other enzymes to accept bulky polyketide substrates.